China channel feed

Gar­dasil de­mand in Chi­na sinks, and Mer­ck ex­pects the same next quar­ter

6 months ago
Pharma

As­traZeneca Chi­na ex­ec probed by lo­cal au­thor­i­ties

6 months ago
Law

WuXi AppTec is still sign­ing on new clients de­spite Biose­cure threat

6 months ago
Manufacturing

BeiGene ex­ec­u­tive re­port­ed­ly un­der in­ves­ti­ga­tion in Chi­na

6 months ago
Pharma

Lawyers pre­dict Biose­cure pas­sage in lame duck ses­sion, but Sen­ate may de­cide key de­tails

7 months ago
Pharma
FDA+

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the draw­ing board’

7 months ago
Manufacturing
Law

Mer­ck KGaA eyes more man­u­fac­tur­ing M&A as it faces head­winds in Chi­na

7 months ago
Manufacturing

Clients add pres­sure to CD­MOs to source raw ma­te­ri­als out­side of Chi­na, ex­ecs say

7 months ago
Manufacturing

WuXi com­pa­nies may sell units im­pact­ed by Biose­cure — re­port

7 months ago
Deals

Ron Re­naud's new obe­si­ty biotech, Kail­era, has $400M to go straight to Phase 3

7 months ago
Financing
Startups

In­sil­i­co Med­i­cine, an ear­ly force in AI-dri­ven drug R&D, lets IPO plans pe­ter out for sec­ond year in a row

8 months ago
Financing
Startups

Gilead­'s Kite un­cou­ples from Fo­s­un in Chi­na as Yescar­ta faces cov­er­age ob­sta­cles

8 months ago
Deals

Con­gress spars over whether the Biose­cure Act is an over­due crack­down or a rushed witch hunt

8 months ago
FDA+
Manufacturing

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

8 months ago
Manufacturing
Law

In­vestors pour $370M+ in­to Ken Song's au­toim­mune biotech af­ter his Rayze­Bio suc­cess

8 months ago
Financing
Startups

Sum­mit's Phase 3 da­ta back up biotech's boasts of beat­ing Keytru­da in lung can­cer

8 months ago
R&D

Ex­clu­sive: In­flu­en­tial De­mo­c­rat will op­pose Biose­cure Act ahead of House vote

8 months ago
Deals
R&D

Lit­tle-known start­up, backed by Fore­site and Sam­sara, swings $60M Chi­na I&I deal

8 months ago
Startups
Deals

Biose­cure vote slat­ed for Sep­tem­ber

8 months ago
FDA+
Law

Sanofi paus­es sup­ply of two flu vac­cines in Chi­na over ‘un­ex­pect­ed cir­cum­stances’ 

8 months ago
Pharma
Manufacturing

Du­al­i­ty Bi­o­log­ics, an ADC part­ner of BeiGene and BioN­Tech, files for Hong Kong IPO

9 months ago
Financing
Startups

Mubadala, CBC Group ink $680M deal for UCB’s neu­rol­o­gy and al­ler­gy port­fo­lio in Chi­na

9 months ago
Deals
Pharma

Up­dat­ed: Chi­nese gov­ern­ment in­dicts Japan­ese Astel­las em­ploy­ee for es­pi­onage

9 months ago
People

WuXi Bio spot­lights new US con­tracts, but prof­its are down as Biose­cure brews

9 months ago
Manufacturing
First page Previous page 1234567 Next page Last page
A service from the Financial Times